We are live on
!
Find out more
BRA
Bender Robert & Associates Portfolio holdings
AUM
$417M
1-Year Est. Return
25.02%
This Fund
S&P 500
This Quarter
Est. Return
+5.24%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$471M
AUM Growth
+$15.6M
(+3.4%)
Cap. Flow
-$2.25M
Cap. Flow
% of AUM
-0.48%
Top 10 Holdings %
Top 10 Hldgs %
75.15%
Holding
80
New
39
Increased
–
Reduced
–
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$90.6M |
| 2 |
NVIDIA
NVDA
|
+$78.2M |
| 3 |
Intuitive Surgical
ISRG
|
+$39.3M |
| 4 |
Amazon
AMZN
|
+$27M |
| 5 |
Mercado Libre
MELI
|
+$25.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 47.43% |
| 2 | Consumer Discretionary | 21.05% |
| 3 | Healthcare | 17.11% |
| 4 | Communication Services | 10.93% |
| 5 | Financials | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Costco
COST
$422B
| $1.27M | 0.27% |
+1,428
| New | +$1.24M |
|
27
AstraZeneca
AZN
$263B
| $1.08M | 0.23% |
+6,941
| New | +$1.12M |
|
28
Gilead Sciences
GILD
$162B
| $950K | 0.2% |
+11,334
| New | +$865K |
|
29
AbbVie
ABBV
$454B
| $855K | 0.18% |
+4,329
| New | +$808K |
|
30
Abbott
ABT
$182B
| $658K | 0.14% |
+5,771
| New | +$633K |
|
31
JPMorgan Chase
JPM
$947B
| $601K | 0.13% |
+2,848
| New | +$600K |
|
32
Johnson & Johnson
JNJ
$641B
| $573K | 0.12% |
+3,539
| New | +$564K |
|
33
Merck
MRK
$323B
| $566K | 0.12% |
+4,982
| New | +$592K |
|
34
Caterpillar
CAT
$402B
| $426K | 0.09% |
+1,089
| New | +$376K |
|
35
Deere & Co
DE
$169B
| $424K | 0.09% |
+1,015
| New | +$383K |
|
36
Nucor
NUE
$56.4B
| $365K | 0.08% |
+2,425
| New | +$365K |
|
37
Oracle
ORCL
$345B
| $332K | 0.07% |
+1,949
| New | +$282K |
|
38
Visa
V
$689B
| $246K | 0.05% |
+894
| New | +$242K |
|
39
American Electric Power
AEP
$72.7B
| $210K | 0.04% |
+2,050
| New | +$200K |
|
|
40
PUT
Apple
AAPL
$4.95T
| – | – |
-417,468
| Closed | -$87.9M |
|
|
41
PUT
AbbVie
ABBV
$454B
| – | – |
-7,466
| Closed | -$1.28M |
|
|
42
PUT
Abbott
ABT
$182B
| – | – |
-5,811
| Closed | -$604K |
|
43
PUT
Adobe
ADBE
$94.5B
| – | – |
-24,111
| Closed | -$13.4M |
|
44
PUT
Advanced Micro Devices
AMD
$807B
| – | – |
-69,442
| Closed | -$11.3M |
|
|
45
PUT
Amazon
AMZN
$2.49T
| – | – |
-148,108
| Closed | -$28.6M |
|
|
46
PUT
AstraZeneca
AZN
$263B
| – | – |
-8,438
| Closed | -$1.32M |
|
47
PUT
Boeing
BA
$167B
| – | – |
-1,983
| Closed | -$361K |
|
48
PUT
Booking.com
BKNG
$145B
| – | – |
-50,825
| Closed | -$8.05M |
|
49
PUT
Bristol-Myers Squibb
BMY
$128B
| – | – |
-24,307
| Closed | -$1.01M |
|
|
50
PUT
Caterpillar
CAT
$402B
| – | – |
-1,139
| Closed | -$379K |
|
Similar funds
AWCI
ACM
PA
CEI
MCM
SSC
SCP
VM
Bender Robert & Associates's Q3 2024 Portfolio in Review
As of Q3 2024, Bender Robert & Associates held 80 positions worth $471M, up 3.4% from $455M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Bender Robert & Associates's Q3 2024 filing shows 39 new and 41 closed positions. Its largest new stake was Apple: 405,831 shares worth $94.6M.
By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 0% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Bender Robert & Associates's largest Q3 2024 buy was Apple: 405,831 shares worth $94.6M.
- Bender Robert & Associates's ten largest holdings make up 75% of its $471M portfolio in Q3 2024.
- Bender Robert & Associates opened 39 new positions and closed 41 in Q3 2024.
- Bender Robert & Associates's portfolio value rose 3.4% quarter-over-quarter to $471M.
Based on Bender Robert & Associates's 13F filing for Q3 2024, filed 30 Oct 2024.